PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis

<div>The role of PPARa and octreotide as tightly interacting transcription factors in hyperlipidemia pancreatitis. IKK: I<i>κ</i>B kinase; HTGP: hyperlipidemia pancreatitis.</div>

PPAR Research

fig5

Figure 5

Figure 5: PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis 